Solve Therapeutics has completed a $120 million unlabelled round as it advances a pair of antibody-drug conjugates (ADCs) for cancer that use its proprietary linker technology. San Diego-based Solve ...
PAID ADVERTORIAL - That familiar feeling of dread can creep in around 7 p.m. on a school night. Your child slides a worksheet across the table, looks up with hopeful eyes, and asks for help with a ...
The worlds of professional sports and entrepreneurship are colliding this summer in Park City, Utah, where elite NFL athletes will meet with proven operators and vetted founders for three days of deal ...
Since the launch of the Crossword in 1942, The Times has captivated solvers by providing engaging word and logic games. In 2014, we introduced the Mini Crossword — followed by Spelling Bee, Letter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results